✦ LIBER ✦

Intravenous clodronate in the prevention of postmenopausal bone loss

✍ Scribed by J. E. Heikkinen; K. S. Selander; K. Laitinen; I. Arnala; H. K. Väänänen

Publisher: Springer-Verlag
Year: 1996
Tongue: English
Weight: 131 KB
Volume: 6
Category: Article
ISSN: 0937-941X
DOI: 10.1007/bf02500621

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of Bone Loss by Clodronate in

Prevention of Bone Loss by Clodronate in Early Postmenopausal Women with Vertebral Osteopenia: A Dose-Finding Study

✍ M. J. Välimäki; K. Laitinen; K. Laitinen; A. Patronen; H. Puolijoki; H. Puolijok 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 314 KB

Prevention of postmenopausal bone loss b

Prevention of postmenopausal bone loss by rectal calcitonin

✍ J. -Y. Reginster; I. Jupsin; R. Deroisy; I. Biquet; N. Franchimont; P. Franchimo 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 400 KB

Prevention of postmenopausal bone loss b

Prevention of postmenopausal bone loss by administration of boron

✍ I. Biquet; J. Collette; JF Dauphin; A. Albert; L. Thunus; G. Deby-Dupont; JY Reg 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 155 KB

Transdermally administered estradiol in

Transdermally administered estradiol in prevention of early postmenopausal bone loss

✍ T. Mošković; S. Runić; A. Dimić 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 129 KB

Prevention of early postmenopausal bone

Prevention of early postmenopausal bone loss with oral tiludronate

✍ C. Roux; R. Deroisy; B. Basse-Cathalinat; B. Combe; P. Geusens; P. J. Meunier; C 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 155 KB

Minimal levels of serum estradiol preven

Minimal levels of serum estradiol prevent postmenopausal bone loss

✍ Jean Yves Reginster; Nathalie Sarlet; Rita Deroisy; Adelin Albert; Uysse Gaspard 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 522 KB

Biochemical parameters reflecting bone resorption [urinary calcium/creatinine (Ca/Cr) and hydroxyproline/creatinine (OH/Cr)] were related to serum estrogens [estrone (E1) and estradiol (E2)] in 262 healthy women including 158 patients receiving estrogen replacement therapy (ERT) for at least 6 month